Sun Pharma Advanced Research Company informs about press release

30 Oct 2023 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sun Pharma Advanced Research Company has informed that it enclosed the Press Release today titled ‘SPARC Completes Enrolment in PROSEEK, A Global Phase 2 Study of Vodobatinib in Early Parkinson’s Disease’, which shall be releasing after sending this letter.

The above information is a part of company’s filings submitted to BSE. 

Sun Pharma Adv. Res Share Price

130.45 -2.80 (-2.10%)
19-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 625.80
Indegene 477.35
CMS Info Systems 330.40
Sagility 53.81
Smartworks Coworking 443.55
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×